References
- Mohassel P, Mammen A. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve 2013;48:477–83.
- Tiniakou E. Statin-associated autoimmune myopathy: current perspectives. Ther Clin Risk Manage 2020;16:483–92.
- SEARCH Collaborative Group; Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, et al. SLCO1B1 variants and statin-induced myopathy – a genomewide study. N Engl J Med 2008;359:789–99.
- Takayuki K, Rider LG, Pak K. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies are associated with DRB1*07:01 and severe myositis in pediatric myositis patients. Arthritis Care Res 2017;69:1088–94.
- Shelly SS, Mielke MM, Pritikanta P, Milone M, Tracy JA, Mills JR, et al. Incidence and prevalence of immune-mediated necrotizing myopathy in adult in Olmsted County, Minnesota. Mucle Nerve 2022;65:541–6.